Clinical Trial Update: Randomized Trial Sorafenib-Pravastatin Versus Sorafenib Alone for the Palliative Treatment of Child-Pugh A Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing sorafenib plus pravastatin versus sorafenib alone for palliative treatment of Child-Pugh A hepatocellular carcinoma; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Nexavar (Sorafenib)
• Pravachol (pravastatin)

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Child-Pugh A Hepatocellular Carcinoma | Phase 3 | Status: COMPLETED